Folgen
Efstathios Iliodromitis
Efstathios Iliodromitis
Bestätigte E-Mail-Adresse bei med.uoa.gr
Titel
Zitiert von
Zitiert von
Jahr
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ...
Polish Heart Journal (Kardiologia Polska) 73 (12), 1207-1294, 2015
12473*2015
Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 …
SG Deftereos, G Giannopoulos, DA Vrachatis, GD Siasos, SG Giotaki, ...
JAMA network open 3 (6), e2013136-e2013136, 2020
4612020
The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits
I Andreadou, EK Iliodromitis, E Mikros, M Constantinou, A Agalias, ...
The journal of nutrition 136 (8), 2213-2219, 2006
3872006
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection
HE Bøtker, D Hausenloy, I Andreadou, S Antonucci, K Boengler, ...
Basic research in cardiology 113, 1-73, 2018
3712018
Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
DJ Hausenloy, JA Barrabes, HE Bøtker, SM Davidson, F Di Lisa, ...
Basic research in cardiology 111, 1-24, 2016
3412016
Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress
I Andreadou, F Sigala, EK Iliodromitis, M Papaefthimiou, C Sigalas, ...
Journal of molecular and cellular cardiology 42 (3), 549-558, 2007
2882007
Ischemic postconditioning: experimental models and protocol algorithms
A Skyschally, P Van Caster, EK Iliodromitis, R Schulz, DT Kremastinos, ...
Basic research in cardiology 104, 469-483, 2009
2552009
Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure
JT Parissis, S Adamopoulos, C Antoniades, G Kostakis, A Rigas, ...
The American journal of cardiology 93 (10), 1309-1312, 2004
2422004
The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote …
I Andreadou, EK Iliodromitis, T Rassaf, R Schulz, A Papapetropoulos, ...
British journal of pharmacology 172 (6), 1587-1606, 2015
2112015
Protection from postconditioning depends on the number of short ischemic insults in anesthetized pigs
EK Iliodromitis, M Georgiadis, MV Cohen, JM Downey, E Bofilis, ...
Basic research in cardiology 101, 502-507, 2006
1772006
The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
SG Deftereos, G Siasos, G Giannopoulos, DA Vrachatis, C Angelidis, ...
Hellenic journal of cardiology 61 (1), 42-45, 2020
1702020
The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits
EK Iliodromitis, A Zoga, A Vrettou, I Andreadou, IA Paraskevaidis, ...
Atherosclerosis 188 (2), 356-362, 2006
1692006
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure
S Adamopoulos, JT Parissis, EK Iliodromitis, I Paraskevaidis, D Tsiapras, ...
The American journal of cardiology 98 (1), 102-106, 2006
1642006
Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning?
EK Iliodromitis, S Kyrzopoulos, IA Paraskevaidis, KG Kolocassides, ...
Heart 92 (12), 1821-1826, 2006
1542006
Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis
N Dagres, C Varounis, T Gaspar, C Piorkowski, C Eitel, EK Iliodromitis, ...
Journal of cardiac failure 17 (11), 964-970, 2011
1332011
Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with …
JT Parissis, S Adamopoulos, D Farmakis, G Filippatos, I Paraskevaidis, ...
Heart 92 (12), 1768-1772, 2006
1322006
Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study
KA Gatzoulis, D Tsiachris, P Arsenos, CK Antoniou, P Dilaveris, S Sideris, ...
European heart journal 40 (35), 2940-2949, 2019
1292019
Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term …
IA Paraskevaidis, EK Iliodromitis, D Vlahakos, DP Tsiapras, A Nikolaidis, ...
European heart journal 26 (3), 263-270, 2005
1282005
Ischemic preconditioning: protection against myocardial necrosis and apoptosis
EK Iliodromitis, A Lazou, DT Kremastinos
Vascular health and risk management 3 (5), 629-637, 2007
1262007
Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in …
V Lambadiari, G Pavlidis, F Kousathana, M Varoudi, D Vlastos, E Maratou, ...
Cardiovascular Diabetology 17, 1-12, 2018
1252018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20